Nicotinamide adenine dinucleotide
NAD+ is a cellular molecule used in energy production, signaling and DNA repair. Injections are claimed to improve energy, mental clarity, recovery and aging.
NAD+ is not a peptide. It is a molecule cells use to turn nutrients into usable energy and to support signaling and DNA repair. NAD+ injections are claimed to improve energy, mental clarity, recovery and aging. A 2026 review found no eligible trials showing that intravenous, intramuscular or subcutaneous NAD+ itself produces those everyday benefits. [1]
Function evidence: Known role inside cells; injection benefits unproven
NAD+ injections are claimed to increase energy, improve mental clarity and recovery, reduce cravings and create a sense of rejuvenation. The fact that every cell uses NAD+ does not show that injecting it produces those effects. A 2026 systematic review found no eligible outcome trials of intravenous, intramuscular or subcutaneous NAD+ itself for anti-aging or wellness. Studies of oral precursors answer different questions and are not evidence for an NAD+ injection. [1,2]
What supports this description: Established cellular role; no eligible injected-NAD+ outcome trials
Dose: No consumer dose is established or recommended here. | Frequency: No routine treatment schedule established. | Cycle: No validated consumer cycle. | Route: No routine patient route established.
Preparation: No patient reconstitution recipe. Trial preparation is not a recommendation..
NAD+ is a coenzyme, not a peptide. A 2026 systematic review found no eligible trials that tested intravenous, intramuscular or subcutaneous NAD+ itself for anti-aging or wellness outcomes. Studies of oral NR and NMN often changed biomarkers, but their clinical results varied and were often null. [1]
No. NAD+ is a coenzyme involved in cellular redox reactions. It is included because peptide clinics commonly offer it alongside peptides. [1]
That has not been established. The 2026 review found no eligible clinical outcome trials of IV, IM, or subcutaneous NAD+ itself for anti-aging or wellness. [1]
Biochemical rationale; clinical wellness claims unestablished. NAD+ is a coenzyme, not a peptide. A 2026 systematic review found no eligible trials that tested intravenous, intramuscular or subcutaneous NAD+ itself for anti-aging or wellness outcomes. Studies of oral NR and NMN often changed biomarkers, but their clinical results varied and were often null. [1]
Approval status: Not FDA-approved. [1,2]
Educational evidence summary. Approval applies only to the named product and indication; compounded, investigational, and research-market products are different categories.